US Patent 11617752 Methods for increasing sepiapterin plasma exposure
Patent 11617752 was granted and assigned to PTC Therapeutics on April, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11617752 Methods for increasing sepiapterin plasma exposure
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
